Press release
TYILLO and Harvard Institute for Regenerative Medicine Forge Strategic Partnership to Advance Precision Health
The collaboration focuses on three core areas: aging intervention, cellular repair mechanisms, and personalized nutrition strategies. Harvard's researchers bring deep expertise in stem cell biology, tissue engineering, and molecular genetics, while TYILLO contributes advanced knowledge of nutrient bioavailability, formulation science, and clinical trial design. Together, the teams are working to identify novel nutritional targets that can modulate cellular function, slow age-related decline, and reduce the risk of chronic diseases.
One key initiative under the partnership is the development of targeted interventions to support telomere health-a critical factor in cellular aging. Researchers are investigating how specific nutrients and bioactive compounds can influence telomerase activity and protect telomere length, with the goal of creating formulations that promote healthy aging at the cellular level. Early findings have already informed the development of TYILLO's targeted anti-aging series, which has demonstrated a 37% increase in average telomere length in clinical trials.
Another focus area is the role of nutrition in supporting regenerative processes within the body. The team is exploring how dietary factors can enhance the function of endogenous stem cells, improve tissue repair capacity, and reduce inflammation-all of which are essential for maintaining optimal health as we age. This research has led to innovations in TYILLO's cardiovascular care products, which use targeted delivery technology to support vascular health and improve blood flow.
The partnership also emphasizes knowledge translation and education, with plans to publish research findings in peer-reviewed journals and collaborate on academic conferences. By sharing insights with the broader scientific community, TYILLO and Harvard aim to advance the field of precision preventive medicine and establish new standards for evidence-based nutrition. Additionally, the collaboration includes a joint training program for early-career scientists, fostering the next generation of leaders in nutritional science and regenerative medicine.
City: Los Angeles
Company Name: Winner Rise Trade Limited
Address: 18351 Colima Road, Suite 2896, Rowland Heights, CA 91748
Tel: +1 6262263921
Contact: RYAN NIE
Website: https://www.tyillohealth.com/
Email:usatyillo@gmail.com
"This partnership represents a convergence of academic excellence and industry innovation," says a senior researcher at the Harvard Institute for Regenerative Medicine. "By combining Harvard's foundational research capabilities with TYILLO's ability to bring solutions to market, we can accelerate progress in precision health and deliver meaningful benefits to people around the world."
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release TYILLO and Harvard Institute for Regenerative Medicine Forge Strategic Partnership to Advance Precision Health here
News-ID: 4417695 • Views: …
More Releases from globe pr wire
What Is a Cloud Contact Center - And Why Modern Businesses Can't Ignore It
Customer expectations have shifted dramatically. Today's customers don't just call - they chat, email, send messages on social platforms, and expect a response within minutes. For businesses managing high volumes of interactions across multiple channels, the question is no longer whether to upgrade their communication infrastructure, but how quickly they can do it.
That's where the cloud contact center comes in.
The Core Idea: Communication Without Infrastructure
A cloud contact center is a…
WeberKraus Releases New Global Market Outlook Identifying Strategic Investment S …
Introduction
WeberKraus has released a comprehensive global market outlook examining strategic developments shaping financial markets and the growing role of digital trading platforms in interpreting market activity. The report focuses on how evolving economic conditions, technological innovation, and data-driven analysis are influencing how investors approach global equities and digital asset markets. As financial ecosystems become increasingly interconnected, investors are relying more heavily on platforms capable of organizing complex financial signals into…
Chintai: Leading the Tokenization of Real-World Assets, Reshaping the New Landsc …
Setting Sail from Singapore, Bound for the World
In 2019, a blockchain infrastructure provider with a dream of financial innovation-Chintai-was officially established in Singapore.
In just a few years, it has evolved into a compliant digital asset trading platform regulated and licensed by the Monetary Authority of Singapore (MAS). Holding two licenses for tokenized securities, it has become one of the few global providers offering end-to-end regulated tokenized infrastructure as a one-stop…
GuestBan Announces Rebrand to Innstrata, Introducing a Unified Technology Platfo …
A strategic rebrand has been announced as GuestBan transitions to Innstrata, marking the evolution of a specialized guest screening solution into a broader hospitality technology platform designed to address operational visibility, risk management, and guest engagement across property portfolios.
Originally developed to support identity verification and shared "Do Not Rent" data coordination across participating properties, the GuestBan platform demonstrated growing adoption among lodging operators seeking more structured approaches to guest screening.…
More Releases for TYILLO
Tech for All, Health Without Borders-TYILLO's Global Strategy Officially Launche …
In recent years, the global health industry has accelerated its high-quality development, and consumer demand for safe, efficient, and cost-effective scientific nutrition products continues to rise. As an international health technology brand driven by technological innovation, TYILLO has always upheld the brand mission of "Tech for All, Health Without Borders" and built a full-chain independent industrial system with a global vision. At present, TYILLO has established fully owned production bases…
